by claudia la via In 2024, the Swiss M&A landscape is predicted to see a robust recovery, marking a stark contrast from the cautious approach witnessed in 2023. As companies align with more stable economic conditions, there’s a palpable shift toward seizing strategic opportunities. This is what PwC Switzerland reports in its Swiss M&A Trend […]
Kontivia Beteiligungen, a Zurich based long term oriented investment firm advised by Kellerhals Carrard, led a group of swiss entrepreneurial families, advised by Baker McKenzie, in the acquisition of a majority stake in Walter Meier (
Homburger advised Biopas on its sale to Swixx Biopharma, a swiss-based global commercial platform focusing on guaranteeing access to innovative medicines worldwide. The founders of Biopas will become shareholders of Swixx Biopharma. The transaction is
Baker McKenzie advised Arbonia on a EUR 100 million bridge loan facility regarding its acquisition of Dimoldura Group and Lignis. The facility was erogated by UBS Switzerland, which was advised by Niederer Kraft Frey (NKF).
Banking & Finance
Capital Markets
Deal & transactions
NKF for UBS Switzerland’s loan facility to Arbonia
Niederer Kraft Frey (NKF) advised UBS Switzerland on a 100 million bridge loan facility for Arbonia’s acquisition of the Dimoldura Group. Arbonia is a building components supplier listed on the SIX Swiss Exchange with annual
Bär & Karrer advises funds managed by Equistone on the sale of KWC Group’s home division, a designer and manufacturer of kitchen, bathroom and washroom fittings and accessories, to Paini Rubinetterie. Bär &
Advestra advised Cactus life sciences, a global scientific communications agency that works with blue chip pharma and biotechnology companies, on nspm and eluSCIdate’
Walder Wyss, together with CastaldiPartners, advised Provost on its acquisition of Mino & Lorenzini. Walder Wyss’ team comprised corporate and M&A partner Luc Defferrard (pictured) and corporate / M&A associate Ken Savioz.
Lenz & Staehelin advised Vaudoise Assurances on all legal and tax aspects of the acquisition of 100% of the share capital of Prevanto. Walder Wyss advised the sellers on all legal aspects of the transaction. Active
Bär & Karrer and Willkie Farr & Gallagher advised PAI Partners (PAI) on the acquisition of Vamed Group’s rehabilitation business (VAMED) from Fresenius, advised by NKF and Latham & Watkins. PAI will become
